Effect of a selective cannabinoid CB1 receptor agonist on spinal nociceptive transmission in carrageenan inflamed anaesthetised rats

被引：0
|
作者：
Kelly, S [1 ]
Chapman, V [1 ]
机构：
[1] Univ Nottingham, Queens Med Ctr, Sch Med, Sch Biomed Sci, Nottingham NG7 2UH, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2001年 / 133卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
162P
引用
收藏
页码：U84 / U84
页数：1
相关论文
共 50 条
  • [21] AM630 is an inverse agonist at the human cannabinoid CB1 receptor
    Landsman, RS
    Makriyannis, A
    Deng, HF
    Consroe, P
    Roeske, WR
    Yamamura, HI
    LIFE SCIENCES, 1998, 62 (09) : PL109 - PL113
  • [22] Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG-018
    Finlay, David B.
    Thuy Nguyen
    Gamage, Thomas F.
    Chen, Shuli
    Barrus, Daniel G.
    Patel, Purvi R.
    Thomas, Brian F.
    Wiley, Jenny L.
    Zhang, Yanan
    Glass, Michelle
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2022, 10 (01):
  • [23] Crystal structures of agonist-bound human cannabinoid receptor CB1
    Tian Hua
    Kiran Vemuri
    Spyros P. Nikas
    Robert B. Laprairie
    Yiran Wu
    Lu Qu
    Mengchen Pu
    Anisha Korde
    Shan Jiang
    Jo-Hao Ho
    Gye Won Han
    Kang Ding
    Xuanxuan Li
    Haiguang Liu
    Michael A. Hanson
    Suwen Zhao
    Laura M. Bohn
    Alexandros Makriyannis
    Raymond C. Stevens
    Zhi-Jie Liu
    Nature, 2017, 547 : 468 - 471
  • [24] An aromatic microdomain at the cannabinoid CB1 receptor constitutes an agonist/inverse agonist binding region
    McAllister, SD
    Rizvi, G
    Anavi-Goffer, S
    Hurst, DP
    Barnett-Norris, J
    Lynch, DL
    Reggio, PH
    Abood, ME
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (24) : 5139 - 5152
  • [25] Effect of hypertension on myocardial cannabinoid CB1 receptor expression
    Gole, Monica S.
    Nagalla, Krishna T.
    Murray, David B.
    FASEB JOURNAL, 2011, 25
  • [26] Levetiracetam combined with ACEA, highly selective cannabinoid CB1 receptor agonist changes neurogenesis in mouse brain
    Zagaja, Miroslaw
    Haratym-Maj, Agnieszka
    Szewczyk, Aleksandra
    Rola, Radoslaw
    Maj, Maciej
    Luszczki, Jarogniew J.
    Andres-Mach, Marta
    NEUROSCIENCE LETTERS, 2019, 696 : 79 - 86
  • [27] Highly selective CB1 cannabinoid receptor ligands and novel CB1/VR1 vanilloid receptor "hybrid" ligands
    Di Marzo, V
    Bisogno, T
    De Petrocellis, L
    Brandi, I
    Jefferson, RG
    Winckler, RL
    Davis, JB
    Dasse, O
    Mahadevan, A
    Razdan, RK
    Martin, BR
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 281 (02) : 444 - 451
  • [28] ACEA, A SELECTIVE CANNABINOID CB1 RECEPTOR AGONIST COMBINED WITH LEVETIRACETAM STIMULATES NEUROGENESIS IN ADOLESCENT MOUSE BRAIN
    Andres-Mach, M.
    Haratym-Maj, A.
    Zagaja, M.
    Rola, R.
    Maj, M.
    Luszczki, J.
    EPILEPSIA, 2015, 56 : 40 - 40
  • [29] THE SELECTIVE CANNABINOID CB1 RECEPTOR AGONIST ACEA ATTENUATES THE DEVELOPMENT OF ISCHAEMIA/REPERFUSION INJURY OF THE MOUSE INTESTINE
    Aviello, G.
    Esposito, E.
    Di Paola, R.
    Mazzon, E.
    Izzo, A. A.
    Capasso, R.
    SHOCK, 2011, 36 : 7 - 8
  • [30] Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodents
    Shearman, Lauren P.
    Stribling, D. Sloan
    Camacho, Ramon E.
    Rosko, Kimberly M.
    Wang, Junying
    Tong, Sharon
    Feng, Yue
    Marsh, Donald J.
    Yu, Hong
    Guan, Xiaoming
    Spann, Stephanie K.
    MacNeil, Douglas J.
    Fong, Tung M.
    Metzger, Joseph M.
    Goulet, Mark T.
    Hagmann, William K.
    Plummer, Christopher W.
    Finke, Paul E.
    Mills, Sander G.
    Shah, Shrenik K.
    Truong, Quang
    Van der Ploeg, L. H. T.
    Maclntyre, D. Euan
    Strack, Alison M.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 579 (1-3) : 215 - 224
12345